XWEL logo

XWELL (XWEL)

Profile

Full Name

XWELL, Inc.

Ticker Symbol

XWEL

Exchange

NASDAQ

Sector

Healthcare

Industry

Diagnostics & Research

Country

United States

IPO

July 27, 2010

Indexes

Not included

Website

http://www.xwell.com

Employees

266

Key Details

Price

$0.75(0.00%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$30.11M(-46.18% YoY)

Annual EPS

-$6.64(+5.28% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.75
XWEL price is $0.75

30-Day Relative Volume

0.06
XWEL 30-day relative volume is 0.06

Price Performance

Price Most recent change

0%
XWEL {parameterFullLabel} has remained unchanged on Apr 16, 2025

Price YTD change

-50.33%
XWEL price is down -50.33% since January 1st

Price 1-year change

-46.04%
XWEL price is down -46.04% year-on-year

Price 3-year change

-96.56%
XWEL price is down -96.56% over the past 3 years

Price Range

Price All-time high

$68760.00
XWEL price is currently -100.00% below its historical high of $68760.00

Price 3-year low

$0.70
XWEL price is currently +7.14% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$3.95M
XWEL market capitalization is $3.95 million

Market cap 3-year change

-96.19%
XWEL market capitalization is down -96.19% over the past 3 years

Market cap All-time high

$80.66B
XWEL market capitalization is currently -100.00% below its historical high of $80.66 billion

Market cap sector rank

11.43%
XWEL market capitalization is higher than 11.43% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+25.78%
XWEL shares outstanding is up +25.78% year-on-year

Shares Outstanding 3-Year Change

+10.67%
XWEL shares outstanding is up +10.67% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

-0.52
XWEL beta is -0.52

200-day SMA

$1.51
XWEL price is currently -50.36% below its 200-day simple moving average

50-day SMA

$1.02
XWEL price is currently -26.61% below its 50-day simple moving average

RSI

35.71
XWEL 14-day relative strength index is 35.71

Volume

0.06
XWEL 30-day relative volume is 0.06

ATR

$0.15
XWEL average true range is $0.15

10-day Historical Volatility

143.60%
XWEL 10-day historical volatility is 143.60%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$30.11M
XWEL annual revenue is $30.11 million

Revenue Analysts estimate

$36.23M
XWEL annual revenue is currently -16.89% lower than the consensus analysts' forecast

Revenue 1-year change

-46.18%
XWEL annual revenue is down -46.18% year-on-year

Revenue Sector rank

39.19%
XWEL annual revenue is higher than 39.19% of companies in Healthcare sector

EPS

EPS

-$6.64
XWEL annual earnings per share is -$6.64

EPS Analysts estimate

-
XWEL annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+5.28%
XWEL annual earnings per share is up +5.28% year-on-year

EPS Sector rank

15.45%
XWEL annual earnings per share is higher than 15.45% of companies in Healthcare sector

Profit

Gross profit

$3.68M
XWEL annual gross profit is $3.68 million

Gross margin

12.23%
XWEL annual gross profit margin is 12.23%

Operating profit

-$19.30M
XWEL annual operating income is -$19.30 million

Operating margin

-64.08%
XWEL annual operating profit margin is -64.08%

Net income

-$27.74M
XWEL annual net profit is -$27.74 million

Net margin

-92.14%
XWEL annual net profit margin is -92.14%

Expenses

Total expenses

$49.40M
XWEL annual total expenses is $49.40 million

Operating expenses

$22.98M
XWEL annual total operating expenses is $22.98 million

Cost of goods sold

$26.43M
XWEL annual cost of goods sold is $26.43 million

Selling, general & administrative expenses

$20.91M
XWEL annual SGA is $20.91 million

Depreciation and amortization

$3.55M
XWEL annual depreciation & amortization is $3.55 million

Interest expense

-
XWEL annual interest expense value is unknown

Income tax

$35.00K
XWEL annual income tax is $35.00 thousand

EBIT & EBITDA

EBIT

-$19.30M
XWEL annual earnings before interest & taxes is -$19.30 million

EBITDA

-$15.75M
XWEL annual EBITDA is -$15.75 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$38.99M
XWEL annual total assets is $38.99 million

Non current assets

$12.43M
XWEL annual long term assets is $12.43 million

Current assets

$26.57M
XWEL annual total current assets is $26.57 million

Cash and cash equivalents

$8.44M
XWEL annual cash & cash equivalents is $8.44 million

Accounts receivable

$1.67M
XWEL annual accounts receivable is $1.67 million

Inventory

$900.00K
XWEL annual inventory is $900.00 thousand

Liabilities

Total liabilities

$18.02M
XWEL annual total liabilities is $18.02 million

Long term liabilities

$8.69M
XWEL annual total long term liabilities is $8.69 million

Current liabilities

$9.33M
XWEL annual total current liabilities is $9.33 million

Accounts payable

$1.10M
XWEL annual accounts payable is $1.10 million

Debt

Total debt

$11.09M
XWEL annual total debt is $11.09 million

Total debt 1-year change

-21.36%
XWEL annual total debt is down -21.36% year-on-year

Long term debt

$8.69M
XWEL annual long term debt is $8.69 million

Short term debt

$2.40M
XWEL annual short term debt is $2.40 million

Equity & Capital

Shareholders equity

$13.00M
XWEL annual stockholders equity is $13.00 million

Book value

$13.00M
XWEL annual book value is $13.00 million

Retained earnings

-$455.85M
XWEL annual retained earnings is -$455.85 million

Working capital

$17.24M
XWEL annual working capital is $17.24 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$16.07M
XWEL annual cash flow from operations is -$16.07 million

Cash from operations 1-year change

+33.55%
XWEL annual cash flow from operations is up +33.55% year-on-year

Cash from investing

$5.65M
XWEL annual cash flow from investing activities is $5.65 million

Cash from investing 1-year change

+116.22%
XWEL annual cash flow from investing activities is up +116.22% year-on-year

Cash from financing

$8000.00
XWEL annual cash flow from financing activities is $8000.00

Cash from financing 1-year change

+100.03%
XWEL annual cash flow from financing activities is up +100.03% year-on-year

CAPEX

CAPEX

$2.37M
XWEL annual capital expenditures is $2.37 million

CAPEX 1-year change

-65.29%
XWEL annual capital expenditures is down -65.29% year-on-year

Free Cash Flow

Free cash flow

-$18.45M
XWEL annual free cash flow is -$18.45 million

Free cash flow 1-year change

+40.54%
XWEL annual free cash flow is up +40.54% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

12.23%
XWEL annual gross profit margin is 12.23%

Operating margin

-64.08%
XWEL annual operating profit margin is -64.08%

Net margin

-92.14%
XWEL annual net profit margin is -92.14%

ROA & ROE

ROA

-50.71%
XWEL annual return on assets is -50.71%

ROE

-80.50%
XWEL annual return on equity is -80.50%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
XWEL price to earnings ratio value is unknown

PE ratio Sector rank

-
XWEL price to earnings ratio is unknown

PB Ratio

PB ratio

0.63
XWEL price to book ratio is 0.63

PB ratio Sector rank

34.35%
XWEL price to book ratio is higher than 34.35% of companies in Healthcare sector

PS Ratio

PS ratio

0.12
XWEL price to sales ratio is 0.12

PS ratio Sector rank

5.38%
XWEL price to sales ratio is higher than 5.38% of companies in Healthcare sector

Enterprise value

Enterprise value

$11.20M
XWEL enterprise value is $11.20 million

Enterprise value Sector rank

26.34%
XWEL enterprise value is higher than 26.34% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.00
XWEL EV/EBITDA is -1.00

EV/EBITDA Sector rank

42.7%
XWEL EV/EBITDA is higher than 42.7% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.85
XWEL annual current ratio is 2.85

Quick ratio

2.75
XWEL annual quick ratio is 2.75

Leverage

Debt to equity

0.00
XWEL annual debt to equity ratio is 0.00

Interest coverage ratio

-
XWEL annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

4
XWEL piotroski f-score is 4

Altman Z-Score

-16.57
XWEL altman z-score is -16.57

Analyst ratings

Recent major analysts updates

Nov 17, 23 HC Wainwright & Co.
Buy
Aug 25, 23 HC Wainwright & Co.
Buy
May 16, 23 HC Wainwright & Co.
Buy
Apr 18, 23 HC Wainwright & Co.
Buy
Apr 4, 23 HC Wainwright & Co.
Buy
Nov 16, 22 HC Wainwright & Co.
Buy
May 18, 22 HC Wainwright & Co.
Buy
Nov 17, 21 HC Wainwright & Co.
Buy
Feb 16, 21 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

CHEK logo
Check-Cap (CHEK)
NUWE logo
Nuwellis (NUWE)
OGEN logo
Oragenics (OGEN)
DRMA logo
Dermata Therapeutics (DRMA)
SNOA logo
Sonoma Pharmaceuticals (SNOA)
XYLO logo
Xylo Technologies (XYLO)
RSLS logo
ReShape Lifesciences (RSLS)
SONN logo
Sonnet BioTherapeutics Holdings (SONN)
RHE logo
Regional Health Properties (RHE)
  • What is the ticker symbol for XWELL?
  • Does XWELL pay dividends?
  • What sector is XWELL in?
  • What industry is XWELL in?
  • What country is XWELL based in?
  • When did XWELL go public?
  • Is XWELL in the S&P 500?
  • Is XWELL in the NASDAQ 100?
  • Is XWELL in the Dow Jones?
  • When was XWELL's last earnings report?
  • When does XWELL report earnings?

What is the ticker symbol for XWELL?

The ticker symbol for XWELL is NASDAQ:XWEL

Does XWELL pay dividends?

No, XWELL does not pay dividends

What sector is XWELL in?

XWELL is in the Healthcare sector

What industry is XWELL in?

XWELL is in the Diagnostics & Research industry

What country is XWELL based in?

XWELL is headquartered in United States

When did XWELL go public?

XWELL's initial public offering (IPO) was on July 27, 2010

Is XWELL in the S&P 500?

No, XWELL is not included in the S&P 500 index

Is XWELL in the NASDAQ 100?

No, XWELL is not included in the NASDAQ 100 index

Is XWELL in the Dow Jones?

No, XWELL is not included in the Dow Jones index

When was XWELL's last earnings report?

XWELL's most recent earnings report was on Apr 16, 2025

When does XWELL report earnings?

The date for XWELL's next earnings report has not been announced yet
On this page